Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF‑β1 signaling in articular cartilage in a rodent osteoarthritis model.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Medicine Reports

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2017.7549PMID 28944864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

  2019cited by this paper
• Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis

  2016cited by this paper
• Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage–bone crosstalk

  2016cited by this paper
• Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.

  2014cited by this paper
• Induction of high temperature requirement A1, a serine protease, by TGF-beta1 in articular chondrocytes of mouse models of OA.

  2014cited by this paper
• OARSI guidelines for the non-surgical management of knee osteoarthritis.

  2014cited by this paper
• Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice.

  2013cited by this paper
• Knee replacement.

  2012cited by this paper
• Osteoarthritis year 2010 in review: pathomechanisms.

  2011cited by this paper
• Osteoarthritis: an update with relevance for clinical practice

  2011cited by this paper
• The bone–cartilage unit in osteoarthritis

  2011cited by this paper
• Osteoarthritis year 2010 in review: pathomechanisms

  2011cited by this paper
• Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis

  2010cited by this paper
• Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders

  2010cited by this paper
• The basic science of the subchondral bone

  2010cited by this paper
• Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy.

  2008cited by this paper
• Differential upregulation of the three transforming growth factor beta isoforms in human osteoarthritic cartilage

  2008cited by this paper
• Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone

  2008cited by this paper
• Osteoarthritis cartilage histopathology: grading and staging.

  2006cited by this paper
• Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours.

  2006cited by this paper
• Contemporary concepts of inflammation, damage and repair in rheumatic diseases.

  2006cited by this paper
• The transforming growth factor-beta superfamily of receptors.

  2004cited by this paper
• Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma.

  2003cited by this paper
• Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients.

  2002cited by this paper
• TGF-β/Smad3 Signals Repress Chondrocyte Hypertrophic Differentiation and Are Required for Maintaining Articular Cartilage

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections.

  2000cited by this paper
• Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis.

  1999cited by this paper
• Halofuginone: a novel antifibrotic therapy.

  1998cited by this paper
• Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta.

  1997cited by this paper
• Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis

  1997cited by this paper
• Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies.

  1996cited by this paper
• The effects of halofuginone and salinomycin, alone and in combination, on live performance and skin characteristics of broilers.

  1995cited by this paper
• Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint.

  1994cited by this paper
• TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases.

  1993cited by this paper
• Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy.

  1992cited by this paper
• Transforming growth factor‐β1 (TGF‐β1) up‐regulation of collagen type II in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing

  1992cited by this paper

• Integrating superlubricative nanomaterials with precision drug delivery for advanced osteoarthritis therapy

  2025cites this paper
• Intra‐Articular Injection of Nanomaterials for the Treatment of Osteoarthritis: From Lubrication Function Restoration to Cell and Gene Therapy

  2024cites this paper
• Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis

  2024cites this paper
• Inhibition of transforming growth factor-β in osteoarthritis. Discrepancy with reduced TGFβ signaling in normal joints

  2022cites this paper
• Cartilage-targeting and inflammatory-responsive nanocarriers for effective osteoarthritis treatment via reactive oxygen species scavenging and anti-angiogenesis

  2022cites this paper
• Icariin accelerates cartilage defect repair by promoting chondrogenic differentiation of BMSCs under conditions of oxygen‐glucose deprivation

  2021cites this paper
• Characteristics of sensory innervation in synovium of rats within different knee osteoarthritis models and the correlation between synovial fibrosis and hyperalgesia

  2021cites this paper
• Raloxifene inhibits the overexpression of TGF-β1 in cartilage and regulates the metabolism of subchondral bone in rats with osteoporotic osteoarthritis

  2020cites this paper
• Endothelial cells produce angiocrine factors to regulate bone and cartilage via versatile mechanisms

  2020cites this paper